BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34760958)

  • 1. Immunogenicity of the Oral Rabies Vaccine Strain SPBN GASGAS in Dogs Under Field Settings in Namibia.
    Molini U; Hassel R; Ortmann S; Vos A; Loschke M; Shilongo A; Freuling CM; Müller T
    Front Vet Sci; 2021; 8():737250. PubMed ID: 34760958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of Oral Rabies Vaccine Strain SPBN GASGAS in Local Dogs in Bali, Indonesia.
    Megawati Saputra IL; Suwarno S; Husein WF; Suseno PP; Prayoga IMA; Vos A; Arthawan IM; Schoonman L; Weaver J; Zainuddin N
    Viruses; 2023 Jun; 15(6):. PubMed ID: 37376704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral Immune Response of Thai Dogs after Oral Vaccination against Rabies with the SPBN GASGAS Vaccine Strain.
    Leelahapongsathon K; Kasemsuwan S; Pinyopummintr T; Boodde O; Phawaphutayanchai P; Aiyara N; Bobe K; Vos A; Friedrichs V; Müller T; Freuling CM; Chanachai K
    Vaccines (Basel); 2020 Oct; 8(4):. PubMed ID: 33019605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Oral Rabies Vaccine Baits Containing SPBN GASGAS in Domestic Dogs According to International Standards.
    Bobe K; Ortmann S; Kaiser C; Perez-Bravo D; Gethmann J; Kliemt J; Körner S; Theuß T; Lindner T; Freuling C; Müller T; Vos A
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term immunity induced by SPBN GASGAS in orally vaccinated dogs is non-inferior to inactivated rabies vaccines.
    Vos A; Kasemsuwan S; Leelahapongsathon K; Bobe K; Perez-Bravo D; Kliemt J; Phawaphutayanchi P; Aiyara N; Freuling CM; Müller T
    Vaccine X; 2023 Dec; 15():100410. PubMed ID: 38075432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and Effectiveness Studies with Oral Vaccination of Free-Roaming Dogs against Rabies in Thailand.
    Chanachai K; Wongphruksasoong V; Vos A; Leelahapongsathon K; Tangwangvivat R; Sagarasaeranee O; Lekcharoen P; Trinuson P; Kasemsuwan S
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33805404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency response using oral rabies vaccination of dogs -field data from Namibia demonstrate high efficiency.
    Freuling CM; Busch F; Shikongo MB; Silume N; van der Westhuizen J; Khaiseb S; Shilongo A; Müller T
    One Health; 2023 Jun; 16():100562. PubMed ID: 37363208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral vaccination of foxes and raccoon dogs against rabies with the 3rd generation oral rabies virus vaccine, SPBN GASGAS, in Finland.
    Vos A; Nokireki T; Isomursu M; Gadd T; Kovacs F
    Acta Vet Scand; 2021 Oct; 63(1):40. PubMed ID: 34645487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the oral rabies virus vaccine strain SPBN GASGAS in foxes and raccoon dogs.
    Freuling CM; Eggerbauer E; Finke S; Kaiser C; Kaiser C; Kretzschmar A; Nolden T; Ortmann S; Schröder C; Teifke JP; Schuster P; Vos A; Mettenleiter TC; Müller T
    Vaccine; 2019 Aug; 37(33):4750-4757. PubMed ID: 29042202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Immunogenicity and Efficacy of the Oral Rabies Virus Vaccine Strain SPBN GASGAS in Foxes.
    Freuling CM; Kamp VT; Klein A; Günther M; Zaeck L; Potratz M; Eggerbauer E; Bobe K; Kaiser C; Kretzschmar A; Ortmann S; Schuster P; Vos A; Finke S; Müller T
    Viruses; 2019 Aug; 11(9):. PubMed ID: 31461981
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of immune responses in dogs to oral rabies vaccine under field conditions.
    Smith TG; Millien M; Vos A; Fracciterne FA; Crowdis K; Chirodea C; Medley A; Chipman R; Qin Y; Blanton J; Wallace R
    Vaccine; 2019 Aug; 37(33):4743-4749. PubMed ID: 29054727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral rabies vaccination of dogs-Experiences from a field trial in Namibia.
    Freuling CM; Busch F; Vos A; Ortmann S; Lohr F; Hedimbi N; Peter J; Nelson HA; Shoombe K; Shilongo A; Gorejena B; Kaholongo L; Khaiseb S; van der Westhuizen J; Dietze K; Geurtse G; Müller T
    PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010422. PubMed ID: 35994498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of shedding with the oral rabies virus vaccine strain SPBN GASGAS in target and non-target species.
    Vos A; Freuling C; Ortmann S; Kretzschmar A; Mayer D; Schliephake A; Müller T
    Vaccine; 2018 Feb; 36(6):811-817. PubMed ID: 29325820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable Long-Term Rabies Immunity in Foxes after IntraMuscular and Oral Application Using a Third-Generation Oral Rabies Virus Vaccine.
    Te Kamp V; Friedrichs V; Freuling CM; Vos A; Potratz M; Klein A; Zaeck LM; Eggerbauer E; Schuster P; Kaiser C; Ortmann S; Kretzschmar A; Bobe K; Knittler MR; Dorhoi A; Finke S; Müller T
    Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33466701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Safety Studies With SPBN GASGAS in the Frame of Oral Vaccination of Foxes and Raccoon Dogs Against Rabies.
    Ortmann S; Kretzschmar A; Kaiser C; Lindner T; Freuling C; Kaiser C; Schuster P; Mueller T; Vos A
    Front Vet Sci; 2018; 5():91. PubMed ID: 29868616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety studies with the oral rabies virus vaccine strain SPBN GASGAS in the small Indian mongoose (Herpestes auropunctatus).
    Ortmann S; Vos A; Kretzschmar A; Walther N; Kaiser C; Freuling C; Lojkic I; Müller T
    BMC Vet Res; 2018 Mar; 14(1):90. PubMed ID: 29534727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
    Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
    Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral bait preferences and feasibility of oral rabies vaccination in Bangladeshi dogs.
    Bonwitt J; Bonaparte S; Blanton J; Gibson AD; Hoque M; Kennedy E; Islam K; Siddiqi UR; Wallace RM; Azam S
    Vaccine; 2020 Jul; 38(32):5021-5026. PubMed ID: 32513512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs and effectiveness of alternative dog vaccination strategies to improve dog population coverage in rural and urban settings during a rabies outbreak.
    Undurraga EA; Millien MF; Allel K; Etheart MD; Cleaton J; Ross Y; ; Wallace RM
    Vaccine; 2020 Sep; 38(39):6162-6173. PubMed ID: 32616327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Non-Meat-Based, Mass Producible and Effective Bait for Oral Vaccination of Dogs against Rabies in Goa State, India.
    Gibson AD; Mazeri S; Yale G; Desai S; Naik V; Corfmat J; Ortmann S; King A; Müller T; Handel I; Bronsvoort BM; Gamble L; Mellanby RJ; Vos A
    Trop Med Infect Dis; 2019 Sep; 4(3):. PubMed ID: 31487795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.